Patent Assignment
Reel/Frame 044377/0915
Change of Name
Recorded: 2017-11-06
Pages: 3
Assignor
KALOBIOS PHARMACEUTICALS, INC.
Executed: 2017-07-21
Assignee
HUMANIGEN, INC.
1000 MARINA BLVD., SUITE 250, BRISBANE, CALIFORNIA, 94005-1878
Covered Property
(1)
Antibody Specificity Transfer Using Minimal Essential Binding Determinants
Related Assignments
(6)
Other recorded transfers of the patent in this record — the chain of ownership.
Security Interest
May 23, 2016
From: KALOBIOS PHARMACEUTICALS, INC.
To: BLACK HORSE CAPITAL, LP
Reel/Frame 038788/0266 →
Security Interest
Dec 22, 2016
From: KALOBIOS PHARAMECUTICALS, INC.
To: BLACK HORSE CAPITAL MASTER FUND LTD.
Reel/Frame 041181/0605 →
Release of Security Interest
Mar 30, 2018
From: BLACK HORSE CAPITAL MASTER FUND LTD.
To: KALOBIOS PHARAMECUTICALS, INC.
Reel/Frame 045788/0148 →
Release of Security Interest
Mar 30, 2018
From: BLACK HORSE CAPITAL MASTER FUND LTD.
To: KALOBIOS PHARAMECUTICALS, INC.
Reel/Frame 045855/0533 →
Security Interest
Jul 16, 2019
From: HUMANIGEN, INC.
To: BLACK HORSE CAPITAL MASTER FUND LTD.
Reel/Frame 049769/0067 →
Release of Security Interest
Jun 12, 2020
From: BLACK HORSE CAPITAL MASTER FUND LTD.
To: HUMANIGEN, INC.
Reel/Frame 052920/0631 →